Skip to Content


In the US, Nilotinib (nilotinib systemic) is a member of the drug class BCR-ABL tyrosine kinase inhibitors and is used to treat Chronic Myelogenous Leukemia.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Cytostatic agent

Tyrosine kinase inhibitor

Chemical Names

4-Metyl-N-[3-(4-metyl-1H-imidazol-1-yl)-5-(trifluorometyl)phenyl]-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzamide (WHO)

4-Metyl-N-[3-(4-metylmidazol-1-yl)-5-trifluormetylphenyl]-3-(4-pyridin-3-ylpyrimidin-2-ylamin)benzamid (IUPAC)

Foreign Names

  • Nilotinibum (Latin)
  • Nilotinib (German)
  • Nilotinib (French)
  • Nilotinib (Spanish)

Generic Names

Brand Names

  • Tasigna
    Novartis, Bosnia & Herzegowina; Novartis, China; Novartis, Greece; Novartis, Hong Kong; Novartis, Israel; Novartis, Lebanon; Novartis, Portugal; Novartis, Slovakia; Novartis, Tunisia; Novartis, Turkey; Novartis, Taiwan; Novartis, Vietnam; Novartis Europharm, Slovenia; Novartis Healthcare, Philippines; Haemato Pharm, Austria; Novartis, Argentina; Novartis, Belgium; Novartis, Chile; Novartis, Czech Republic; Novartis, Denmark; Novartis, Egypt; Novartis, Finland; Novartis, France; Novartis, Croatia (Hrvatska); Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Iceland; Novartis, Japan; Novartis, South Korea; Novartis, Lithuania; Novartis, Netherlands; Novartis, Norway; Novartis, New Zealand; Novartis, Oman; Novartis, Poland; Novartis, Romania; Novartis, Serbia; Novartis, Sweden; Novartis, Thailand; Novartis, United States; Novartis AH, South Africa; Novartis Europharm, Austria; Novartis Europharm Limited, Latvia; Novartis Farma, Italy; Novartis Farmaceutica, Spain; Novartis Pharma, Switzerland; Novartis Pharma, Germany; Novartis Pharma, Russian Federation; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom


BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.